12.2 Monitoring Fluid Balance, Blood Pressure & Cardiovascular Risk

Monitoring Fluid Balance, Blood Pressure & Cardiovascular Risk

Cardiovascular disease (CVD) is the undisputed leading cause of mortality in end-stage renal disease, responsible for 45% to 50% of all patient deaths. Unlike the general population, where atherosclerotic coronary artery disease predominates, cardiovascular mortality in dialysis is largely driven by sudden cardiac death, lethal arrhythmias, and heart failure secondary to structural cardiac remodeling. At the center of this pathophysiological vulnerability is chronic extracellular fluid volume expansion. In maintenance hemodialysis (HD) and peritoneal dialysis (PD), longitudinal surveillance of fluid balance, blood pressure patterns, and ultrafiltration kinetics is essential to preserve cardiac architecture and extend patient survival.

---

Longitudinal Tracking of Fluid Parameters & Dry Weight

Clinical fluid balance is anchored to the concept of Estimated Dry Weight (EDW) (or target dry weight). EDW is defined as the lowest post-dialysis weight a patient can safely tolerate without experiencing intradialytic hypotension, muscle cramping, lightheadedness, or nausea, and in the absence of clinical signs of hypervolemia (e.g., peripheral edema, jugular venous distension, pulmonary rales, or uncontrolled hypertension).

Interdialytic Weight Gain (IDWG) Dynamics

Interdialytic Weight Gain reflects fluid accumulation between dialysis sessions resulting from oral fluid and sodium consumption. Because absolute weight gain must be contextualized against patient body mass, IDWG should always be evaluated as a percentage of estimated dry weight: $\% \text{IDWG} = \frac{\text{Pre-dialysis Weight} - \text{Prior Post-dialysis Weight}}{\text{Estimated Dry Weight (EDW)}} \times 100\%$

┌────────────────────────────────────────────────────────────────────────────────────────┐
│                     IDWG Clinical Risk Stratification Matrix                           │
├──────────────────────────┬─────────────────────────────┬───────────────────────────────┤
│ % IDWG of Dry Weight     │ Absolute Gain (70 kg EDW)   │ Clinical Status & Action      │
├──────────────────────────┼─────────────────────────────┼───────────────────────────────┤
│ <4.0% of EDW             │ <2.8 kg (Optimal)           │ Target achieved; minimal      │
│                          │                             │ myocardial wall stress.       │
├──────────────────────────┼─────────────────────────────┼───────────────────────────────┤
│ 4.0% – 5.0% of EDW       │ 2.8 – 3.5 kg (Moderate)     │ Acceptable over long weekend; │
│                          │                             │ review dietary sodium sources.│
├──────────────────────────┼─────────────────────────────┼───────────────────────────────┤
│ >5.0% of EDW             │ >3.5 kg (Excessive / High)  │ Elevated LV wall stress; UFR  │
│                          │                             │ safety ceiling breach risk.   │
├──────────────────────────┼─────────────────────────────┼───────────────────────────────┤
│ >7.0% of EDW             │ >4.9 kg (Severe Overload)   │ Critical risk of pulmonary    │
│                          │                             │ edema, CHF, and acute death.  │
└──────────────────────────┴─────────────────────────────┴───────────────────────────────┘

Programs commonly aim to keep IDWG below about 4.0% to 5.0% of EDW (roughly <2.0 to 2.5 kg between midweek sessions), accepting somewhat more over the long weekend break. Excessive fluid intake is primarily driven by osmotic thirst resulting from high dietary sodium intake; every 8 grams of sodium chloride consumed (~3,200 mg sodium) obligates the retention of approximately 1 liter (1.0 kg) of water to maintain extracellular osmolarity.

---

Cardiovascular Remodeling: Concentric vs. Eccentric Hypertrophy

Chronic volume and pressure overloads impose severe, continuous biomechanical stress on the myocardium, inducing two distinct patterns of Left Ventricular Hypertrophy (LVH):

1. Eccentric LVH (Volume Overload Remodeling): Chronic interdialytic fluid accumulation elevates cardiac preload and left ventricular end-diastolic volume (LVEDV). To accommodate this increased diastolic wall stretch, cardiac myocytes replicate sarcomeres in series, causing left ventricular chamber dilation accompanied by proportional or inadequate wall thickening. Eccentric LVH leads to progressive ventricular dilation, functional mitral regurgitation, elevated pulmonary capillary wedge pressures, secondary pulmonary hypertension, and heart failure with preserved or reduced ejection fraction.
2. Concentric LVH (Pressure Overload Remodeling): Sustained systemic hypertension, increased arterial stiffness from medial vascular calcification (Mönckeberg sclerosis), and narrowed microvasculature increase cardiac afterload. Myocytes replicate sarcomeres in parallel, causing concentric inward wall thickening with reduced cavity dimension. This markedly impairs diastolic relaxation and coronary perfusion.

Combined eccentric and concentric remodeling is present in up to 75% to 80% of incident dialysis patients, creating an electrophysiologically unstable substrate highly vulnerable to lethal re-entrant ventricular tachyarrhythmias and sudden cardiac arrest.

---

Blood Pressure Surveillance & Paradoxical Intradialytic Hypertension

Routine surveillance protocols recommend targeting a pre-dialysis blood pressure of <140/90 mmHg and a post-dialysis blood pressure of <130/80 mmHg, individualized for frail patients or those with severe coronary artery disease:

• Intradialytic Hypotension (IDH): Defined as a decrease in systolic blood pressure of ≥20 mmHg (or a mean arterial pressure drop ≥10 mmHg) associated with symptoms (nausea, dizziness, muscle cramps, yawning) requiring clinical intervention. IDH occurs when the ultrafiltration rate outpaces the capillary refilling rate from the interstitial space into the intravascular compartment.
• Paradoxical Intradialytic Hypertension: In approximately 10% to 15% of hemodialysis patients, blood pressure behaves paradoxically, defined as an increase in systolic blood pressure of ≥10 mmHg from pre-dialysis to post-dialysis (or during the latter half of the treatment). Rather than reflecting adequate volume removal, intradialytic hypertension is a manifestation of underlying chronic volume overload and neurohormonal dysregulation:
  • Endothelial Dysfunction: Hemodialysis ultrafiltration triggers an acute release of Endothelin-1 (ET-1), a potent vasoconstrictor peptide, from damaged vascular endothelium, while endothelial nitric oxide synthase (eNOS) activity is blunted.
  • Sympathetic Hyperactivity: Contraction of intravascular volume in a chronically overhydrated patient paradoxically activates the sympathetic nervous system, inducing intense peripheral arterial vasoconstriction.
  • Inappropriate Renin Secretion: Despite systemic volume expansion, rapid fluid extraction from the central circulation diminishes effective renal perfusion in native kidneys with residual tissue, stimulating paradoxical renin-angiotensin-aldosterone axis activation.
  • Management: The primary treatment is gradual probing of dry weight (reducing EDW by 0.2 to 0.5 kg increments per week) and restricting dietary sodium, rather than merely intensifying pre-dialysis antihypertensive medications.

---

Ultrafiltration Rate (UFR) Monitoring & Clinical Safety Ceilings

During hemodialysis, fluid is extracted across the dialyzer membrane via hydrostatic ultrafiltration. The rate of fluid removal relative to patient body weight and treatment duration is quantified by the Ultrafiltration Rate (UFR): $\text{UFR}\ (\text{mL/kg/h}) = \frac{\text{Total Fluid Removed (mL)}}{\text{Post-dialysis Weight (kg)} \times \text{Treatment Time (hours)}}$

                                 The Cascade of Excessive UFR (>13 mL/kg/h)

  Ultrafiltration Rate >13 mL/kg/h       Vascular Refilling Rate Mismatch         Intravascular Hypovolemia
  ┌───────────────────────────────┐     ┌────────────────────────────────┐     ┌────────────────────────────┐
  │ Rapid fluid extraction from   │ ──> │ Capillary refill from tissues  │ ──> │ Acute central intravascular│
  │ intravascular space           │     │ (~10–12 mL/kg/h) cannot keep up│     │ volume collapse            │
  └───────────────────────────────┘     └────────────────────────────────┘     └────────────────────────────┘
                                                                                              │
                  ┌───────────────────────────────────────────────────────────────────────────┘
                  ▼
  ┌────────────────────────────────────────────────────────────────────────────────────────────────────────┐
  │                               Multi-Organ Ischemic & Endothelial Consequences                         │
  ├────────────────────────────┬─────────────────────────────┬─────────────────────────────────────────────┤
  │ Organ System               │ Ischemic Mechanism          │ Clinical Manifestation                      │
  ├────────────────────────────┼─────────────────────────────┼─────────────────────────────────────────────┤
  │ Myocardium                 │ Coronary microvascular      │ Repetitive myocardial stunning, transient   │
  │                            │ hypoperfusion during HD     │ regional wall motion abnormalities, fibrosis│
  ├────────────────────────────┼─────────────────────────────┼─────────────────────────────────────────────┤
  │ Central Nervous System     │ Cerebral white matter       │ Microvascular cerebral ischemia, silent     │
  │                            │ hypoperfusion               │ lacunar infarcts, cognitive decline         │
  ├────────────────────────────┼─────────────────────────────┼─────────────────────────────────────────────┤
  │ Splanchnic Bed & Gut       │ Intestinal hypoperfusion &  │ Mucosal barrier breakdown, bacterial        │
  │                            │ mucosal ischemia            │ lipopolysaccharide (endotoxin) translocation│
  └────────────────────────────┴─────────────────────────────┴─────────────────────────────────────────────┘

The 13 mL/kg/h Threshold in Quality Oversight

UFR is not a current ESRD QIP measure, but the CMS Measures Assessment Tool (citing NQF #2701) directs surveyors to look for avoidance of UFR at or above 13 mL/kg/h, and large cohort studies (including DOPPS) link higher UFR with rising cardiovascular and all-cause mortality. When UFR exceeds 13 mL/kg/h:

1. Myocardial Stunning: Echocardiographic studies demonstrate transient regional wall motion abnormalities (RWMAs) in up to about two-thirds of hemodialysis patients studied, even in the absence of obstructive coronary artery disease. Over months of repetitive stunning, the myocardium undergoes irreversible scarring and fibrotic replacement, culminating in fixed systolic dysfunction and sudden cardiac death.
2. Gut Endotoxemia: Splanchnic vasoconstriction induces intestinal mucosal ischemia, disrupting tight junctions and permitting gut bacterial endotoxins (lipopolysaccharides) to enter the systemic circulation, perpetuating chronic uremic microinflammation.

Strategies to Remediate Elevated UFR

When surveillance reveals UFRs >13 mL/kg/h, the renal dietitian and interdisciplinary team must implement three direct interventions:

1. Restrict Dietary Sodium: Strict sodium reduction to <2,000 mg/day (<87 mEq/day) suppresses osmotic thirst, directly reducing IDWG.
2. Extend Dialysis Treatment Time: Increasing treatment duration from 3.5 hours to 4.0 or 4.5 hours lowers the hourly fluid extraction rate without reducing total fluid clearance.
3. Increase Treatment Frequency: Transitioning eligible patients to short daily home hemodialysis (5–6 days/week) or nocturnal hemodialysis distributes fluid removal across more hours, dramatically reducing peak UFR.